Popular Articles
Today Week Month Year


HISTORY REPEATS: Pfizer paid out $1.2B after its drug caused thousands of BREAST CANCER cases
By Arsenio Toledo // Jan 19, 2023

In 2012, Pfizer agreed to pay out over $1.2 billion to settle over 10,000 cases involving its hormone-replacement drug Prempro, with over half of the cases alleging that the drug caused breast cancer.

Up until 1995, menopausal women that required hormone replacement therapy combined two drugs – Premarin and Provera – that provided estrogen and progestin. But following 1995, Big Pharma company Wyeth released Prempro, which combined the two hormones into one pill. Pfizer would acquire Wyeth in 2009 following a $68 billion purchase. (Related: NEVER FORGET: In 1994, Pfizer paid $20 million after LYING about defective heart valve that killed hundreds.)

More than six million women took Prempro to treat menopause symptoms like hot flashes and mood swings before 2002, when a landmark study was released highlighting the drug's links to cancer. Wyeth's sales of the medicines before the release of this study exceeded $2 billion.

Pfizer settles over 10,000 cases after years of protracted litigation

Pfizer lost 11 of 21 cases in trials decided by juries until it finally agreed to settle. The drug maker got some of the verdicts against it thrown out after trial or had awards reduced. It resolved thousands of other cases through settlements, while other decisions went to appeal.

Despite the settlements and the overwhelming evidence against Prempro, Pfizer still claims that its drug works.

"After nine years of litigation involving this medicine, we are confident in our medicine, our track record of success in court where we have won eight of the last 10 final verdicts at trial, and in our ability to resolve these cases on appropriate terms," said a Pfizer spokesman at the time in a statement emailed to Bloomberg.

We are building the infrastructure of human freedom and empowering people to be informed, healthy and aware. Explore our decentralized, peer-to-peer, uncensorable Brighteon.io free speech platform here. Learn about our free, downloadable generative AI tools at Brighteon.AI. Every purchase at HealthRangerStore.com helps fund our efforts to build and share more tools for empowering humanity with knowledge and abundance.

Pfizer settled about 6,000 lawsuits for a total sum of over $896 million. The company has also set aside an additional $330 million to resolve another 4,000 suits. Some of these 10,000 cases have been consolidated in a federal court in Arkansas, while the other suits went through state courts in Nevada, Minnesota and Pennsylvania.

The reserve means Pfizer committed more than $1.2 billion to resolve claims against Prempro, or an average of $150,000 per case. But information from some of the trials suggests that some plaintiffs were awarded millions or even tens of millions of dollars, including punitive damage for Pfizer's actions in withholding information about Prempro's breast cancer risk.

In one trial resolved earlier that year, a federal jury in Connecticut ordered Pfizer to pay a woman who developed breast cancer from Prempro use $4 million in damages. The panel also ordered Pfizer to pay punitive damages over its handling of the Prempro scandal.

Many women still seeking damages from Pfizer

Despite settling the 10,000 cases, dozens of women at the time were still going through the courts and preparing for another round of trials over Prempro.

Esther Berezofsky, a New Jersey-based lawyer who represented women suing Pfizer over its menopause drugs, said her clients believe their claims are worth more than the average $150,000 the Big Pharma company paid in the settlements.

"We'll consider settling when the company decides to fairly compensate the women I represent for the horrendous injuries caused by these drugs," she said.

"The law firms that are left after these settlements are eager to see that every woman gets her day in court," said Zoe Littlepage at the time. Littlepage is a Houston-based lawyer who represented several women who refused to settle their suits against Pfizer. "We have worked long and hard to get these cases to trial."

Learn more about Big Pharma companies like Pfizer at BigPharmaNews.com.

Watch this clip from InfoWars featuring Israeli Prime Minister Benjamin Netanyahu admitting Israelis were used as guinea pigs for Pfizer.

This video is from the InfoWars channel on Brighteon.com.

More related articles:

NEVER FORGET: Jury found Pfizer guilty of violating antiracketeering law.

CRIME CARTEL: Pfizer paid out $2.3 billion in a settlement to Washington for illegally promoting its drugs.

PFIZER FLASHBACK: Pfizer sued by 30 Nigerian families for using children as human guinea pigs in illegal clinical trial.

NEVER FORGET: Blue Cross Blue Shield's 2010 lawsuit named several Pfizer execs involved in kickback scheme.

NEVER FORGET: Pfizer manipulated studies to convince doctors to prescribe seizure drug Neurontin for off-label use.

Sources include:

FiercePharma.com

Bloomberg.com

BizNews.com

Brighteon.com



Take Action:
Support NewsTarget by linking to this article from your website.
Permalink to this article:
Copy
Embed article link:
Copy
Reprinting this article:
Non-commercial use is permitted with credit to NewsTarget.com (including a clickable link).
Please contact us for more information.
Free Email Alerts
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.

NewsTarget.com © 2022 All Rights Reserved. All content posted on this site is commentary or opinion and is protected under Free Speech. NewsTarget.com is not responsible for content written by contributing authors. The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. NewsTarget.com assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms and those published on this site. All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.

This site uses cookies
News Target uses cookies to improve your experience on our site. By using this site, you agree to our privacy policy.
Learn More
Close
Get 100% real, uncensored news delivered straight to your inbox
You can unsubscribe at any time. Your email privacy is completely protected.